Vitamin C Supplement

Emergen-c

133 adverse event reports submitted to the FDA · 2010–2025 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 133 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Choking
9
Diabetes mellitus
8
Nephrolithiasis
8
Hypersensitivity
8
Malaise
8
Cough
8
Dizziness
7
Coeliac disease
6
Feeling abnormal
6
Pruritus
5

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

OutcomeReports
Other Serious or Important Medical Event 109
Hospitalization 14
Visited a Health Care Provider 12
Visited Emergency Room 12
Death 8
Other Outcome 4
Other Serious Outcome 3
Disability 2
Congenital Anomaly 1
Life Threatening 1
Allergic Reaction 1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18
1
18–34
12
35–49
10
50–64
23
65–79
15
80+
4
Unknown
68

65 reports had age data; 68 unknown.

Gender

Female
69
Male
37
Unknown/Not Reported
27

Reports by Year

Annual report counts from 2010–2025. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Hover bars for exact counts.

← View all Emergen-C products in FDA data

Related Products

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗  ·  About our methodology  ·  How to read this data